Featured Article
The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Latest Features
The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Managing Heart Failure: Improving Quality of Life and Preventing Excerbations
Heart failure is the number 1 reason for patient re-admittance to acute-care facilities according to the American Heart Association.
Preventing Heart Failure One Risk Factor at a Time
Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.
Hope for Heart Failure in Thyroid Hormone Therapy
Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.
Premature Ventricle Contractions in Heart Failure: A Closer Examination
A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.
ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD
While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.
Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"
Drs Tauras and Patel from Montefiore Medical Center in the Bronx, New York weigh in on what the new heart failure therapeutic guidelines mean for practicing clinicians.
Managing Cardiovascular Complications of Oncology Treatment
Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.
Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure
Ixmyelocel-T therapy reduced clinical cardiac events and improved patient outcomes.
Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD
Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.
Latest News
Missed Diagnosis of New-Onset Systolic Heart Failure Common in Children
Investigators assessed the frequency of missed diagnosis of new-onset systolic heart failure at first presentation in children with no known heart disease.
Emergency Department Barthel Index Score Predicts Heart Failure Mortality
Investigators evaluated the value of the Barthel Index (BI) to predict 30-day mortality risk among patients with acute heart failure who go to the emergency department.
Moderate Alcohol Use Associated With Heart Failure Survival Benefit
Consumption of 7 or fewer drinks per week was associated with significantly longer survival following the diagnosis of heart failure compared with abstinence.
Quality of Life, Treatment Suboptimal in Women With HFrEF
Future studies should address the sex-related differences in evaluating therapeutic strategies for women with heart failure with reduced ejection fraction.
Elevated RDW Associated With Pulmonary Hypertension, Heart Failure
Findings are hypothesis-generating, as they highlight the potential shared pathophysiology of pulmonary hypertension and elevated red cell distribution width.
Self-Reported Weight Provides Prognostic Information for Future Heart Failure Risk
Self-reported weight history by ethnically diverse middle-aged to older patients is independently provides prognostic information about future heart failure risk.
High-Density Lipoprotein Particle Subfractions Higher in HFrEF
Investigators sought to determine whether patients with HFrEF have more severe derangements in high-density lipoprotein particle subfractions compared with patients with HFpEF.
FDA to Review Tafamidis for Treatment of Transthyretin Amyloid Cardiomyopathy
Tafamidis is an oral small molecule candidate that selectively binds at specific sites on the transthyretin tetramer to prevent destabilization of the transthyretin transport protein and formation of amyloid that causes ATTR-CM.
Catheter Ablation Superior to Drug Therapy for Atrial Fibrillation in Heart Failure
Catheter ablation is superior to drug therapy in improving all-cause mortality, LVEF, 6-minute walk test distance, VO2max, and quality of life in patients with heart failure.
Patient With Heart Failure Coughs Up Bronchial Tree-Shaped Blood Clot
A recently published case report describes the case of a 36-year-old male chronic heart failure patient who, "spontaneously expectorated an intact cast of the right bronchial tree," following an extreme bout of coughing.
The Cardiology Advisor Articles
- Statins in Patients Older Than 75: A Meta-Analysis of 28 Controlled Trials
- Infection and Infarction: Cause and Effect?
- Open Surgical Repair of Descending Thoracic Aortic Aneurysms Linked to Early Postoperative Mortality
- Emergency Department Barthel Index Score Predicts Heart Failure Mortality
- Reversal Agent Reduces Severe Bleeding With Factor Xa Inhibitors
- Societies Release Updated Guidelines for the Management of Atrial Fibrillation
- FDA: Unauthorized INR Test Strips Part of Large Recall
- Does Rivaroxaban Plus Aspirin Prevent Early Coronary Bypass Graft Occlusion?
- Banding Together: How Some Physicians Are Fighting the MOC Program
- Swan-Ganz Thermodilution Catheters Recalled Due to Lumen Reversal
- Machine Learning Algorithm May Guide Therapy in Adult Congenital Heart Disease
- Linagliptin Non-Inferior to Glimepiride in Long-Term CV Outcome Study
- No Association Between LDL Cholesterol Levels and Risk for Sepsis
- PAH Therapy Guidelines Updated by CHEST Expert Panel
- Protecting Patient Privacy: HIPAA Compliance in the Electronic Age